Ziv Harel, MD, MSc

Lithium is an important mood disorder treatment, but the renal risks in older adults are unclear. This population-based cohort study looked at risk of renal decline with lithium vs...

Could mood-stabilizing medications be increasing patients' risk of developing kidney disease? This large, nested case-control study looks at the degree of risk associated with lithium and valproate treatment in...